Galafold 123 mg, Kapseln

7680661080011 CH-66108 Kapseln

Associated product:

GALAFOLD caps 123 mg 14 pce
Galafold 123 mg, Kapseln
Galafold 123 mg, Kapseln
Galafold 123 mg, Kapseln
1 / 3
google

Article details

Package size
14
Selling units
14
Measure
Kapsel(n)
Galenic form
Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
11/06/2025
Patient information leaflet
Français
11/06/2025
Patient information leaflet
Italien
11/06/2025
Summary of Product Characteristics
Allemand
11/06/2025
Summary of Product Characteristics
Français
11/06/2025
Summary of Product Characteristics
Italien
11/06/2025

Detailed composition

Substance Quantity Type Category
(N/A)
123.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FIMDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 18431.65
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/03/2017

Authorization holder

Amicus Therapeutics Switzerland GmbH

8008 Zürich

Authorization information

Swissmedic authorization number
66108
Drug name
Galafold, Kapseln
Galenic form
KAHA
ATC Code
A16AX14
Authorization status
Z
Dispensing category
B
First authorization
28/10/2016
Authorization expiration date
31/12/9999
IT Number
07.99.0.
Domain
Human medicine
Field of application
Morbus Fabry

Package details

Description (FR)
GALAFOLD caps 123 mg 14 pce
Description (DE)
GALAFOLD Kaps 123 mg 14 Stk
Market launch
28/10/2016
Narcotic (BTM)
No